Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Have a diagnosis of RA for less than or equal to 3 years~* Be 18 years of age or older at the time of diagnosis~Exclusion Criteria:~* Pregnant or lactating women~* History of chronic infection, such as hepatitis, pneumonia, or chronic skin infections~* Active TB or evidence of latent TB

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): methotrexate (MTX) + etanercept
- 2 (Type: ACTIVE_COMPARATOR): methotrexate (MTX) + sulfasalazine (SSZ)/hydroxychloroquine (HCQ)
- 3 (Type: ACTIVE_COMPARATOR): methotrexate (MTX) or MTX + Etanercept
- 4 (Type: ACTIVE_COMPARATOR): methotrexate (MTX) or MTX + sulfasalazine (SSZ)/hydroxychloroquine (HCQ)

Based on this trial design, predict the completion outcome and termination type (if applicable).